Pharming Group
A global biopharmaceutical company developing and commercializing innovative protein replacement therapies and precision medicines to serve the unserved rare disease patient.
Milestones
- Founded 1988
- Partnered 1995
- IPO 1998
A global biopharmaceutical company developing and commercializing innovative protein replacement therapies and precision medicines to serve the unserved rare disease patient.